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A B S T R A C T
Background: Diarrhea is a leading cause of morbidity and mortality among under-five children in
Bangladesh. Hospitalization for diarrhea can pose a significant burden on households and health systems.
The aim of this study was to estimate the cost of illness due to diarrhea from the healthcare facility,
caregiver, and societal perspectives in Bangladesh.
Method: A cross-sectional study with an ingredient-based costing approach was conducted in 48
healthcare facilities in Bangladesh. In total, 899 caregivers of under-five children with diarrhea were
interviewed face-to-face between August 2017 and May 2018, followed up over phone after 7–14 days of
discharge, to capture all expenses and time costs related to the entire episode of diarrhea.
Results: The average cost per episode for caregivers was US$62, with $29 direct and $34 indirect costs.
From the societal perspective, average cost per episode of diarrhea was $71. In 2018, an estimated $79
million of economic costs were incurred for treating diarrhea in Bangladesh. Using 10% of income as
threshold, over 46% of interviewed households faced catastrophic expenditure from diarrheal disease.
Conclusion: The economic costs incurred by caregivers for treating per-episode of diarrhea was around 4%
of the annual national gross domestic product per-capita. Investment in vaccination can help to reduce
the prevalence of diarrheal diseases and avert this public health burden.
© 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Background
Diarrhea is identified as one of the leading causes of infectious
deaths worldwide among children under five, resulting in an
estimated 526 000 deaths per year or nearly 1500 childhood
deaths each day (Liu et al., 2016; Schroder et al., 2019). In low- and
middle-income countries (LMICs), diarrhea is the most common
cause of childhood illness and healthcare visits, especially in South
Asia. (Black et al., 2008). As in many other LMICs, diarrhea is one of
the major public health problems in Bangladesh, with persistent
diarrhea prevalent throughout the year.
Diarrhea is defined as a condition that involves unusually
frequent and liquid bowel movements; more than three or more
times in a 24-h period. The disease can be characterized as ‘acute
watery’ if it lasts less than 14 days, ‘persistent’ if it lasts more than
14 days, and ‘invasive’ if caused by infection due to pathogens
(WHO, 2002; Alam and Ashraf, 2003). Unsafe water, poor
sanitation and hygiene, and malnutrition are major risk factors
for childhood diarrheal disease (WHO, 2014). Studies have shown
that diarrheal disease is associated with episodes of flooding,
contaminated drinking water, poor personal hygiene, and socio-
economic factors (Hoque et al., 1996; Sack et al., 2006; Wu et al.,
2011a,b). Moreover, extreme weather factors, such as higher
temperatures and rainfall, increase the incidence of childhood
diarrhea (Wu et al., 2014).* Corresponding author at: Health Economics and Financing, Health Systems and
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lso have a catastrophic economic impact on households due to
ut-of-pocket (OOP) payments for healthcare. These economic
mpacts disproportionately burden the poorest households com-
ared with the richest (Khan et al., 2017).
Several types of intervention are available for the treatment of
iarrheal disease. These include oral rehydration solutions, zinc
reatment, continued feeding, and antibiotic treatment for certain
trains of diarrhea (cholera, shigella, and cryptosporidiosis). These
iarrheal treatments are available in all types of health facility in
he Bangladesh health system, which comprizes public providers,
rivate for-profit (PFP) providers, and private not-for-profit (PNFP)
roviders. The public health facilities under the Directorate
eneral of Health Services (DGHS) is divided into different tiers:
ational, divisional, district, upazila (sub-district), union/ward, and
ommunity. People have almost free access to these facilities. The
FP health sector includes large and small hospitals, medical
ractitioners (i.e., doctors and individual providers), and informal
ealthcare providers. The PNFP providers mostly focus on
aternal, child, and adolescent healthcare services in Bangladesh.
hese services are offered in both rural and urban areas, and are
ften free for the poor population. In addition to this, a large
umber of patients seek care from non-professional providers
Chowdhury et al., 2015).
According to WHO, immunization through vaccination can
revent a number of diseases, most of which can have serious
omplications (WHO 2012). Since 1979, Bangladesh has initiated
he Expanded Program on Immunization (EPI) as an integral part of
angladesh’s efforts to reduce child mortality due to vaccine-
reventable diseases. Most of the vaccines included in the EPI are
unded by the Global Alliance for Vaccines and Immunizations
Gavi) (DGHS, 2015). Although vaccines are globally regarded as
one of the most cost-effective public health interventions, gaps
exist in the evidence base relating to their broader economic
impact, including the cost of illness averted due to vaccination in
LMICs. There is also an overall lack of guidelines on best practices
for primary data collection in LMICs relating to cost-of-illness
analyses for major childhood diseases.
A number of studies have been conducted in many other LMICs
on the cost of illness of diarrheal disease (Mendelsohn et al., 2008;
Rheingans et al., 2012a; Burke et al., 2014). However, limited
studies are available that capture the total costs of diarrheal
episodes at different levels of the health system. Such studies have
an important role in policy making and evidence generation for
international comparisons. Despite several existing studies on the
economic impact of diarrheal disease in Bangladesh (Rheingans
et al., 2012b; Sarker et al., 2013, 2018, 2019; Das et al., 2015), none
of them captured information from all relevant levels of the health
system, and few estimated the aggregate societal costs of diarrheal
disease and the impact that diarrheal disease had on households.
Recently, Bangladesh’s income status classification was rede-
fined from low-income to LMIC by the World Bank (The World
Bank Group, 2018), which will accelerate the country’s transition
out of Gavi’s donor support in providing necessary immunization
services. It is vital to understand the economic impact conferred by
diarrhea vaccination and thereby provide evidence to support
ongoing investment in vaccination programs. In this context, the
cost-of-illness studies of childhood diarrhea can provide critical
information to stakeholders for use in evidence-based financial
planning and decision making.
Evidence on the cost of illness of diarrhea generated through
this study will be useful in conducting the cost-effectiveness
analysis of diarrheal interventions in future, which is an important
criterion for assessing prevention programs in Bangladesh. Thus,Figure 1. Map of the study sites; based on the United Nations Map No. 3711, Rev. 2, January 2004.
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due to diarrhea from the healthcare facility, caregiver, and societal
perspectives in Bangladesh, and to examine how the OOP spending
relating to diarrhea leads to catastrophic healthcare expenditure
(CHE) among households in which children under five are suffering
from diarrheal disease. The specific objectives are as follows:
i To estimate the cost drivers of diarrheal disease.
ii To estimate the average economic cost (both financial and
indirect) of treating diarrhea among the different types of
health facility.
iii To estimate the impact of OOP spending resulting from
diarrheal disease on CHE for households whose children under
five are suffering from diarrhea.
Methods
Study design
Our study involved an incidence-based cross-sectional study
design, paired with an ingredient-based costing approach in order
to capture the costs associated with a full episode of diarrheal
disease. The cost of treating diarrhea beyond 14 days after the
initial discharge was not assessed.
Study population and sites
In order to better represent overall immunization coverage in
Bangladesh, we purposively selected a low-performing division,
Sylhet (61.1%), and a high-performing division, Rajshahi (83.6%), as
study sites (DGHS, 2013). For each of the two selected divisions,
one rural district and one city corporation (each division has one
city corporation) were selected. Within each selected district or
city corporation there were different health facility tiers (e.g.,
primary level facility with or without inpatient care, secondary
level facility, and tertiary level facility) with different types of
ownership (e.g., public, PFP, and PNFP). In Moulvibazar district of
Sylhet division there are 222 public, 13 PFP, and 17 PNFP facilities
and in Natore district of Rajshahi division there are 224 public, 22
PFP, and 14 PNFP facilities. Of the two city corporations, there are
three public, 34 PFP, and 23 PNFP facilities in Sylhet city
corporation and eight public, 63 PFP, and 39 PNFP facilities in
Rajshahi city corporation (MOHFW, 2020). To capture at least one
facility from each type of ownership and one facility from each
level, 19 facilities from each district and five from each city
corporation (24 from each division) were selected (Figure 1). These
included 30 public and 18 PFP and PNFP facilities. The facilities
were selected according to the number of measles, pneumonia, and
diarrhea cases reported for the prior year (2015–16).
For the caregiver’s perspective, adult caregiver(s) (aged over 18
years) of the selected children (aged 0–59 months) were included.
The target patients in each facility were identified through clinical
assessment and were not necessarily confirmed by laboratory
tests. Cases with comorbidities were excluded.
For collecting data on facility-level costs from the provider
perspective, administrators and managers of public healthcare
facilities, along with medical staff, laboratory technicians, statis-
ticians, and storekeepers, were recruited.
Data collection
Interviews were carried out with administrators and managers
of the public healthcare facilities to collect cost data from the
provider perspective, and with medical staff, laboratory techni-
cians, statisticians, and storekeepers for data on healthcare
utilization from August 2017 to May 2018. Administrative records
were used to support or adjust estimates when required. Data were
collected from the pediatric ward only for cases in tertiary- and
secondary-level hospitals.
Two healthcare facility surveys were conducted. From the first
survey, data on the costs of different medical items and the average
time spent by different healthcare professionals on diarrhea cases
were collected. The second was a monthly follow-up facility
survey, which captured the overhead costs from annual expenses
and utilization rates for supplies and medications from inventories.
Additional data on medication pricing in the private sector were
collected via interviews with pharmacy owners or pharmacists in
charge of selected pharmacies.
For hospitalized cases, caregivers were interviewed during
discharge from the facility and followed up by phone within 7–14
days. For outpatient cases, caregivers of sick children were
interviewed as they were exiting the facility. During these
interviews, information was obtained about OOP payments for
the treatment of their child’s diarrhea before being admitted to the
hospital or outpatient clinic, while in the hospital or outpatient
clinic, and after being discharged from the hospital or outpatient
clinic. These included payments for their child’s hospital stay,
medications, tests, and procedures, as well as transportation costs,
and the costs of meals and lodging relating to their child’s illness.
Information on time devoted to providing care for the children
(productivity loss) while in the hospital or outpatient clinic and
post discharge was also obtained. Different costs items are
presented in Table 1. Finally, information was collected on the
characteristics of the respondents’ households, household expen-
ditures, and income of the members to assess their socioeconomic
Table 1
Summary table of cost items.
Types of cost Included cost items Types of survey




Patient caregiver survey and follow-
up survey






Patient caregiver survey and follow-
up survey
Household indirect (costs incurred not for medical management of the disease but Wage losses for the patient caregiver due to Patient caregiver survey and follow-
through losses such as lost wages) care of the patients up survey
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ousehold.
osting methods
Costs were reported in 2018 US$, using a conversion rate of 1
SD = 83.5 Bangladeshi takas (BDT) (The World Bank, 2019). Cost
ategories were defined according to Jo (2014).
All costs from the public provider perspective were patient-
pecific with the exception of overhead, labor, and capital costs.
he latter items were estimated as shared costs on the basis of
atients in a pediatric ward. The capital costs items were
nnualized over their useful lifetime at a 3% discount rate. A
ifetime of 50 years for infrastructure and 5 years for medical
quipment was assumed (Hoque et al., 2011). The costs for
verhead, labor, and capital consumed to treat an episode of
iarrhea were estimated on the basis of patient-days (see Eq. (1)).









n Eq. (1), S is the total cost attributable to diarrhea, c the total
nnual cost for overheads, labor, and capital, p is the number of
atients using the health facility in 1 year (with losi the length of
tay in days for caregiver i over n total caregivers) and for
ealthcare facility j over m total facilities.
However, in some facilities there were wards dedicated to
iarrhea treatment. In these cases, the capital costs associated with
ach ward were calculated according to utilization of the ward by
iarrhea cases only. If the capital item was shared across the whole
ediatric ward, in these cases the capital costs were calculated
ased on the utilization rate of the whole pediatric ward. Patient-
pecific utilization was considered for combining all other costs.
All direct costs of the caregivers were itemized. Indirect costs
ere estimated using a human capital approach, considering the
verage income of the household head and the time spent getting
o/from the healthcare facility, in the healthcare facility, and
providing care at home after discharge. Additionally, the detailed
time losses for the caregivers, along with their indirect costs, were
reported.
A one-way ANOVA was applied for testing the variances of
different types of cost for treating an episode of diarrhea (e.g.,
direct, indirect, and total costs) by the child’s gender, the
household’s residence (urban or rural), the type of visit (inpatient
or outpatient), the type of facility (public, PFP, or PNFP), and the
length of stay. Based on the one-way ANOVA, if the assumption of
equal variance was not supported, Wilcoxon–Mann–Whitney tests
were applied for independent variables with two categories and
Kruskal–Wallis tests for the independent variables with more than
two categories. If the assumption of equal variance was supported,
t-tests were applied.
Societal costs were estimated by combining caregiver costs and
provider costs for each illness. Private facilities are not subsidized
and charge all the costs to the caregivers through fees and
copayments. Provider costs were only applicable for public
facilities because these facilities are subsidized by the government.
However, for estimating the societal costs, the costs incurred by the
caregivers and those incurred by the public providers were
combined. The country-level costs for diarrhea were estimated by
multiplying the societal costs per episode by the national incidence
of diarrhea cases for 2018.
Principal component analysis
Principal component analysis (PCA) was applied to classify the
households into different categories of socioeconomic status,
based on the household’s dwelling characteristics and the
possession of durable assets. The PCA scores were generated
using household dwelling characteristics (e.g., roof, wall, and floor
materials, sources of water, types of sanitation use, and utilities)
and the possession of durable goods (e.g., mobile phones and
televisions) (Vyas and Kumaranayake, 2006). Using the scores
generated from PCA, the households were divided into asset
quintiles.
able 2
ample characteristics of diarrhea patients and caregiver of patients in Bangladesh.
Characteristics Diarrhea cases (n = 899) Characteristics Diarrhea cases (n = 899)
n % n %
Age-group Asset quintiles
0–5 months 104 12% Poorest 180 20%
6–11 months 258 28% 2nd 181 20%
12–24 months 404 45% 3rd 179 20%
More than 24 months 133 15% 4th 180 20%
Gender of the child Richest 179 20%
Female 322 36% District
Male 577 64% Maulvibazar district (rural) 302 34%
Gender of the caregiver Natore district (rural) 307 34%
Female 713 79% Rajshahi city corporation (urban) 147 16%
Male 186 21% Sylhet city corporation (urban) 143 16%
Education of the caregiver Type of service
No education 26 3% Inpatient service 586 65%
Primary incomplete 80 9% Outpatient service 313 35%
Primary complete 191 21% Length of stay at IPD
Secondary incomplete 321 36% Up to 4 days 510 87%
Secondary complete 281 31% 5 days or more 76 13%
Residence location Type of facilities
Rural 678 75% Public 548 61%
Urban 221 25% Private for-profit 348 39%
Household size (excluding sick child) Private not-for-profit 3 <1%
1–3 persons 133 15%
4–5 persons 413 46%
6 persons or more 353 39%
40
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The proportion of households that faced CHE from diarrheal
treatment was estimated using several definitions of CHE (Pradhan
and Prescott, 2002; Wagstaff and van Doorslaer, 2003; Xu et al.,
2003, 2006; Russell, 2004). If direct OOP expenditure (direct
medical and direct non-medical) for an episode of diarrhea
exceeded a certain threshold of monthly income of the household
head or the monthly household expenditures, the household was
said to face CHE. The total monthly household expenditure
comprized both food expenditure and non-food expenditure.
We classified A household was classified as experiencing CHE
related to an episode of diarrhea when OOP expenditure for the
episode exceeded a certain threshold. Two such thresholds were
applied for determining the incidence of CHE: i) 10% or 25% of total
household expenditure, as used by Wagstaff and van Doorslaer
(2003); and ii) 40% of non-food consumption expenditure as a
proxy of the household’s capacity to pay, as used by O’Donnell et al.
(2008) and Xu et al. (2003).
Results
In total, 899 diarrhea episodes were captured during the data
collection period, of which 586 were inpatient cases (65%) and 313
were outpatient cases (35%). Most children were under the age of 2
years (766 children, 85%) and most were male (577, 62%). Over 79%
of the caregivers were women. A majority of caregivers were living
in rural areas (678, 75%). The majority of the patients had a length
of stay of less than 5 days (510, 87.0%). The majority of the cases
were from public healthcare facilities (548 children, 61%) followed
by private for-profit facilities (348, 39%). Only three children (<1%)
were recruited in private not-for-profit facilities (Table 2).
Provider costs of treatment
Table 3 shows the provider costs of treatment in public
facilities. Overall, the government facilities spent about $23 for a
hospitalized case and about $7 for an outpatient case on providing
care. Primary healthcare facilities had an average total cost of $9 for
outpatient care and $24 for a hospitalized case of diarrhea.
Secondary and tertiary healthcare facilities had average total costs
of $8 and $9 to treat an outpatient case and $16 and $27 for a
hospitalized case, respectively.
In all facility levels, the main drivers of facility costs were those
reported for medication and labor, for both inpatients and
outpatients.
Caregiver cost of treatment
Table 4 shows that for inpatient care, caregivers spent less in
public healthcare facilities than in PFP and PNFP facilities. On
average, for a hospitalized case of diarrhea in a public facility, $47
Table 3
Government costs for an episode of diarrhea in 2018 US dollars by types of care at different levels of facility.
Cost Inpatient cases Outpatient cases
Primary healthcare facilities without inpatient capabilities (n = 14)a
Mean SE 95% CI Mean SE 95% CI
Capital 0.53 0.38 0.30 0.74
Overhead 0.00 0.00 0.00 0.00
Labor 2.46 1.83 1.40 3.51
Supplies 0.00 0.00 0.00 0.00
Medications 0.00 0.00 0.00 0.00
Total cost 4.05 0.78 2.37 5.71
Primary healthcare facilities with inpatient capabilities (n = 12)
Capital 0.63 0.14 0.31 0.96 0.24 0.05 0.12 0.36
Overhead 0.47 0.04 0.38 0.54 0.18 0.01 0.14 0.20
Labor 4.35 0.49 3.25 5.45 1.63 0.18 1.22 2.04
Supplies 0.04 0.01 0.01 0.06 0.01 0.00 0.00 0.02
Medications 16.79 3.16 9.63 23.94 6.29 1.19 3.60 8.97
Total cost 24.48 3.47 16.61 32.34 9.17 1.31 6.23 12.11
Secondary healthcare facility (n = 2)
Capital 0.23 0.04 0.11 0.34 0.11 0.01 0.06 0.17
Overhead 1.35 0.53 0.32 3.04 0.66 0.25 0.16 1.46
Labor 3.04 0.71 0.77 5.31 1.46 0.35 0.37 2.55
Supplies 0.10 0.07 0.12 0.31 0.05 0.04 0.06 0.14
Medications 7.80 4.63 6.95 22.54 3.75 2.23 3.34 10.84
Total cost 15.68 3.99 2.97 28.37 7.53 1.92 1.43 13.64
Tertiary healthcare facility (n = 2)
Capital 2.04 0.28 1.50 5.56 0.66 0.08 0.48 1.78
Overhead 0.38 0.10 0.81 1.58 0.12 0.04 0.26 0.50
Labor 8.24 2.49 23.34 39.82 2.65 0.80 7.51 12.80
Supplies 0.59 0.42 4.81 5.98 0.19 0.13 1.54 1.92
Medications 11.20 1.38 6.32 28.71 3.60 0.44 2.04 9.23
Total cost 27.27 1.23 11.59 42.95 8.77 0.40 3.72 13.81
All facilities with IPD (n = 16) All facilities with OPD (n = 30)
Capital 0.71 0.16 0.36 1.06 0.38 0.06 0.26 0.50
Overhead 0.68 0.16 0.34 1.01 0.16 0.05 0.06 0.26
Labor 4.51 0.57 3.30 5.71 2.06 0.25 1.54 2.58
Supplies 0.12 0.06 0.01 0.25 0.02 0.01 0.00 0.05
Medications 13.84 2.42 8.68 19.00 2.84 0.70 1.41 4.26
Total cost 22.63 2.54 17.21 28.05 6.53 0.74 5.02 8.05
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ayments. Caregivers using PFP and PNFP facilities for hospitali-
ation incurred average total costs of $134 and $116, including $66
nd $63 in OOP expenses, respectively.
For outpatient cases, caregivers using public and PNFP facilities
pent, on average, about $7 and $3, respectively, including $4 and
2 in OOP expenses. Caregivers using PFP facilities spent over $24,
ncluding $16 in OOP expenses (Table 5).
Over the continuum of care for an episode of diarrhea that
equired hospitalization, the majority of the cost incurred was for
urrent visit, accounting for 67%, 81%, and 81% of the total cost
ncurred in public, PFP, and PNFP facilities, respectively. Relative to
otal expenses, indirect costs from productivity loss were a
ignificant contributor to economic losses across all types of
acility and types of care, ranging from 38% to 64% (percentages are
ot shown in Table 5).
Table 6 shows the direct, indirect, and total costs across
ifferent characteristics of patients and caregivers. Overall, an
pisode of diarrhea incurred costs of about $62 for caregivers in
018, with average OOP payments of $29 and indirect costs of $34
Table 6). Costs were driven primarily by hospitalization and the
se of private facilities. Total costs for infants under 2 years old
anged from $58 to $76, which dropped significantly to $38 for
hildren over 2 years old (p = 0.000). There was a significant
ifference in direct costs between male and female children, with
ale children costing on average $30 and females $25 (p = 0.030.
ale children were slightly more likely to be hospitalized (67% vs
2%) and were more likely to be treated in a private for-profit
ealthcare facility (34% vs 27%).
Most caregivers in our sample resided and sought care in rural
areas (75%) (Table 2). While caregivers residing in urban areas were
more likely than rural dwellers to seek PFP healthcare for both
inpatient (39% vs. 29%) and outpatient care (10% vs 6%) (Table S1),
no statistical differences in direct and indirect costs were observed.
The average direct costs in city corporations area ($53) was found
to be significantly higher than in rural districts area ($17; p =
0.000).
When the lengths of stay for hospitalized patients were longer
(5 days or more), direct costs ($71) were significantly higher
compared with stays of less than 5 days ($36; p < 0.000). Indirect
costs ($94) were also significantly higher for longer stays
compared with stays of less than 5 days ($43; p < 0.000).
The direct and indirect costs were also significantly different
between the poorest asset quintiles and the richest (p < 0.000),
with the costs increasing with richer quintiles. The total cost of
treatment for diarrheal cases among patients belonging to the
poorest quintile was $34, compared with $97 for the richest
quintile. Both direct and indirect costs were also lower among the
poorest quintiles and higher among the richest quintiles.
Economic burden
Over 46% of the households had spending of over 10% of the
household head’s monthly income on each episode of diarrhea.
Considering the household’s consumption expenditure, 47% of the
households faced CHE at the 10% threshold of household
expenditures, with 14% incurring costs of over 25% of their
monthly household expenditures. When excluding food, 30% of the
able 4
otal household costs for a hospitalized episode of diarrhea in 2018 US dollars by types of healthcare facilities.
Timing Types of cost/time loss Public healthcare facilities (n = 302) Private for-profit healthcare facilities (n = 283)
Mean SD 95% CI n (c > 0) Mean SD 95% CI n (c > 0)
Before current visita Direct medical 2.32 3.08 1.98 2.67 214 3.77 4.28 3.27 4.26 230
Direct non-medical 0.14 0.71 0.06 0.23 31 0.80 2.79 0.48 1.13 63
Indirect 9.93 9.69 8.83 11.03 302 19.08 17.70 17.01 21.15 283
Time loss [days] 0.50 0.44 0.45 0.55 302 0.63 0.37 0.59 0.67 283
Current visit Direct medical 2.44 2.46 2.17 2.73 302 34.05 22.95 31.37 36.74 283
Direct non-medical 9.65 7.68 8.79 10.53 302 24.62 26.86 21.47 27.76 283
Indirect 20.01 16.04 18.19 21.82 302 50.75 88.48 40.41 61.11 283
Time loss [days] 0.98 0.58 0.91 1.05 302 1.57 1.16 1.43 1.71 283
Follow-upa Direct medical 2.14 2.06 1.90 2.37 251 2.40 2.77 2.07 2.72 215
Direct non-medical 0.38 2.87 0.06 0.71 20 0.05 0.28 0.01 0.07 15
Indirect 0.56 3.88 0.13 1.01 22 0.16 2.41 0.12 0.44 7
Time loss [days] 0.03 0.18 0.01 0.05 22 0.00 0.01 0.00 0.00 7
Total direct (financial) cost 17.10 10.24 15.94 18.26 302 65.68 44.72 60.44 70.91 283
Total economic cost 47.47 32.06 43.84 51.10 302 135.60 129.98 120.40 150.81 283
Timing Types of cost/time loss Private not-for-profit healthcare facilities (n = 1) All healthcare facilities (n = 586)
Mean SD 95% CI n (c > 0) Mean SD 95% CI n (c > 0)
Before current visita Direct medical 0.00b – – – 0 3.02 3.77 2.71 3.32 444
Direct non-medical 0.00 – – – 0 0.46 2.02 0.30 0.62 94
Indirect 21.56 – – – 1 14.40 14.86 13.17 15.60 586
Time loss [days] 1.00 – – – 1 0.56 0.41 0.53 0.60 586
Current visit Direct medical 45.15 – – – 1 17.78 22.53 15.95 19.62 586
Direct non-medical 17.96 – – – 1 16.90 20.84 15.21 18.59 586
Indirect 30.87 – – – 1 34.87 64.36 29.65 40.10 586
Time loss [days] 1.43 – – – 1 1.27 0.95 1.19 1.34 586
Follow-upa Direct medical 0.00 – – – 0 2.26 2.43 2.06 2.46 466
Direct non-medical 0.00 – – – 0 0.22 2.08 0.05 0.38 35
Indirect 0.00 – – – 0 0.37 3.25 0.11 0.63 29
Time loss [days] 0 – – – 0 0.02 0.13 0.01 0.03 29
Total direct (financial) cost 63.11 – – – 1 40.63 40.10 37.38 43.89 586
Total economic cost 115.54 – – – 1 90.16 103.02 81.80 98.50 586
otes:SD, standard deviation; n (c > 0), number of caregivers with costs over zero takas.
a Includes costs incurred by public and private healthcare facilities and providers.
b Respondent did not report any specific types of cost.
42
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household expenditure (Figure 2).
The proportion of households that faced CHE decreased from
the poorest to the richest asset quintiles. When considering
consumption expenditure, excluding food, over 40% of households
in the poorest asset (1st) quintile faced CHE, compared with 29%,
18%, 27%, and 16% in the 2nd, 3rd, 4th, and 5th quintiles,
respectively (Figure 3).
Societal costs and country costs of diarrhea
From the societal perspective, an episode of diarrhea had an
average cost of $71. The societal cost for a hospitalized episode of
diarrhea was $100 and that for an outpatient episode was $16. In
terms of hospital types by facility ownership, the societal cost of a
hospitalized episode was $66 when using public facilities and $135
when utilizing PFP facilities. For outpatient care, the
lowest societal cost was associated with PNFP facilities, at $3
while public and PFP facilities followed with $14 and $24,
respectively (Figure 4).
The incidence data for 2018 showed that, at a facility level,
around 1 122 681 cases were reported throughout the year (DGHS,
2020). Using the average societal cost, the aggregate annual
economic cost of diarrhea for 2018 in Bangladesh was estimated at
approximately $79 million, or about 0.029% of 2018 GDP.
$23 on providing care for a hospitalized case and about $7 for an
outpatient case.
In a recent study conducted in 2015, Sarker et al. estimated that
the average total societal cost per episode at tertiary-level public
healthcare facilities in Bangladesh was $67 (equivalent to $74 in
2018), which was similar to our estimate of $71 (Sarker et al., 2013).
In another study, Sarker et al. found that caregivers spent $29 ($31
in 2018) for an episode of diarrhea, whereas for hospitalized care
and outpatient care spending was $44 ($49 in 2018) and $12 ($14 in
2018), respectively. Our study found that overall caregiver costs
averaged $62, which was significantly higher than those found by
Sarker et al. (2013). Our higher estimate is likely due to our explicit
consideration of patients from public, PFP, and PNFP facilities,
while the previously mentioned study only included tertiary-level
public facilities. In Bangladesh, costs for treating patients are
comparatively lower in public healthcare facilities than in PFP
facilities, because the public hospitals are highly subsidized
(Andaleeb, 2000). Similar findings have also been observed in
India, where the cost per diarrheal episode in private facilities was
three times higher than for low-cost concessional hospitals and 25
times higher compared with government hospitals (Sowmyanar-
ayanan et al., 2012). Additionally, the caregiver cost per episode at
public facilities found in our study ($29) was similar to the
estimates found in the India study.
Another study, conducted by Das et al., found that, on average, a
Table 5
Total household costs for an outpatient episode of diarrhea in 2018 US dollars by types of healthcare facility.
Timing Types of cost/time loss Public healthcare facilities (n = 246) Private for-profit healthcare facilities (n = 65)
Mean SD 95% CI n (c > 0) Mean SD 95% CI n (c > 0)
Before current visita Direct medical 0.50 1.28 0.35 0.66 92 1.52 2.13 0.99 2.05 37
Direct non-medical 0.01 0.07 0.00 0.02 5 0.08 0.46 0.02 0.20 6
Indirect 0.62 1.60 0.42 0.83 246 2.00 12.10 0.99 4.99 65
Time loss [days] 0.03 0.08 0.02 0.04 246 0.06 0.29 0.02 0.13 65
Current visit Direct medical 0.07 0.35 0.04 0.12 167 4.78 6.00 3.29 6.26 64
Direct non-medical 1.05 1.90 0.81 1.29 210 3.14 9.07 0.89 5.38 63
Indirect 1.98 3.90 1.49 2.47 246 5.64 18.06 1.16 10.11 65
Time loss [days] 0.09 0.16 0.07 0.11 246 0.19 0.45 0.07 0.30 65
Follow-upa Direct medical 1.78 1.99 1.53 2.04 197 4.68 4.13 3.66 5.71 61
Direct non-medical 0.12 1.05 0.01 0.25 11 0.63 1.99 0.13 1.13 11
Indirect 0.37 4.60 0.20 0.95 16 1.32 5.45 0.04 2.67 9
Time loss [days] 0.02 0.18 0.00 0.04 16 0.02 0.09 0.00 0.04 9
Total direct (financial) cost 3.56 3.87 3.07 4.04 246 14.83 15.66 10.95 18.71 65
Total economic cost 6.53 10.37 5.22 7.83 246 23.77 44.18 12.83 34.73 65
Timing Types of cost/time loss Private not-for-profit healthcare facilities (n = 2) All healthcare facilities (n = 313)
Mean SD 95% CI n (c > 0) Mean SD 95% CI n (c > 0)
Before current visita Direct medical 0.06 0.08 0.71 0.83 2 0.71 1.54 0.54 0.89 131
Direct non-medical 0.00 0 0.02 0.22 0.00 0.05 11
Indirect 0.48 0.37 2.89 3.86 2 0.91 5.69 0.28 1.54 313
Time loss [days] 0.03 0.01 0.08 0.14 2 0.04 0.15 0.02 0.05 313
Current visit Direct medical 0.24 0.00 0.24 0.24 1 1.05 3.34 0.68 1.43 232
Direct non-medical 0.69 0.05 0.31 1.07 2 1.49 4.51 0.98 1.99 275
Indirect 1.26 0.59 4.01 6.53 2 2.73 9.01 1.72 3.74 313
Time loss [days] 0.07 0.01 0.01 0.14 2 0.11 0.25 0.08 0.14 313
Follow-upa Direct medical 0.69 0.38 2.73 4.11 2 2.38 2.83 2.07 2.69 260
Direct non-medical 0.00 – – – 0 0.23 1.32 0.08 0.37 22
Indirect 0.00 – – – 0 0.56 4.78 0.04 1.10 25
Time loss [days] 0.00 – – – 0 0.02 0.16 0.00 0.04 25
Total direct (OOP) cost 1.68 0.42 2.13 5.49 2 5.88 9.11 4.87 6.90 313
Total economic cost 3.43 0.54 1.41 8.25 2 10.08 23.11 7.52 12.66 313
Notes: SD, standard deviation; n (c > 0), number of caregivers with costs over zero Takas.
a Includes costs incurred by public and private healthcare facilities and providers.Discussion
The average estimated societal cost per episode of diarrhea was
$71, with an average cost of $100 incurred per hospitalized case
and $16 per outpatient case. The government facilities spent about43household incurred $7 ($9 in 2018) for diarrheal treatment of
under-5 children in rural Bangladesh. However, this study did not
consider the indirect cost from productivity loss of the caregiver
due to time spent treating their sick children (Das et al., 2015).
Rheingans et al., in a multi-country analysis, estimated that the
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nism for healthcare, with more than 67% of total health
expenditure represented by OOP payments (MOHFW, 2017). Such
a high reliance on OOP healthcare expenditure is a concern for
Bangladesh due to OOP spending’s association with poverty
through CHE. Moreover, our study found that caregiver costs in
the poorest quintile were significantly higher than with those in
the richer or richest quintiles, despite lower levels of private
facility utilization. In the 1st (poorest) and 2nd quintiles, the use of
private for-profit healthcare was 18% and 27%, respectively, while
in the 4th and 5th (richest) quintiles, it was 54% and 65%
(Supplementary Table S2). Despite lower levels of private health-
care utilization, the households in the poorest quintile faced equal
or higher levels of CHE compared with households in the richest
quintile (Figure 2). Similar findings have been observed in other
studies (Chima et al., 2003; Sarker et al., 2013).
Our study estimated that the annual aggregate economic
burden of diarrhea for treating cases of under five years of age in
able 6
ifferences in household costs across characteristics of children and caregivers in 2018 US dollars.
Characteristic n Direct costs Indirect costs Total costs
Mean SE p-valueb Mean SE p-valueb Mean SE p-valueb
Overall 899 28.53 1.22 – 33.74 2.12 – 62.28 3.09 -
Age group
<6 months 104 26.77 3.86 0.000c 31.71 4.79 0.000c 58.48 8.41 0.000c
6–11 months 258 31.94 2.37 44.50 6.32 76.44 8.18
12–24 months 404 30.18 1.87 32.06 1.86 62.24 3.51
>24 months 133 18.31 2.35 19.56 2.41 37.88 4.50
Gender (child)
Female 322 25.41 1.89 0.019c 30.37 2.63 0.078c 55.78 4.23 0.030c
Male 577 30.29 1.59 35.62 2.96 65.89 4.18
Gender (caregiver)
Female 713 26.54 1.25 0.001c 31.93 1.74 0.036c 58.48 2.75 0.016d
Male 186 36.18 3.49 40.67 7.78 76.85 10.47
Study area
City corporation 290 52.89 2.73 0.000c 60.83 5.78 0.000c 113.71 7.83 0.000c
Sylhet 143 50.89 3.09 0.569c 49.94 4.68 0.008c 100.84 6.99 0.435c
Rajshahi 147 54.92 4.55 72.01 10.63 126.95 14.12
Rural district 609 16.95 0.95 20.84 1.17 37.78 1.94
Maulvibazar 302 20.48 1.65 0.001c 29.93 1.89 0.000c 50.41 3.26 0.000c
Natore 307 13.46 0.92 11.90 1.19 25.37 1.89
Residence
Rural 678 29.59 1.44 0.131d 35.23 2.67 0.182c 64.83 3.81 0.123c
Urban 221 25.29 2.30 29.15 2.60 54.44 4.57
Type of visit
Inpatient 586 40.63 1.65 0.000c 49.51 3.02 0.000c 90.16 4.25 0.000c
Outpatient 313 5.88 0.51 4.20 0.86 10.08 1.31
Facilities
Public 548 11.02 0.44 0.000c 18.07 1.01 0.000c 29.09 1.37 0.000c
PFP 348 56.18 2.43 58.54 4.96 114.72 6.78
PNFP 3 22.16 20.48 18.63 16.90 40.79 37.38
Length of stay (IPD)a
<5 days 510 36.06 1.50 0.000c 42.90 3.15 0.000d 78.96 4.26 0.000c
5 days 76 71.39 6.91 93.88 8.19 165.27 13.29
Asset quintiles
Poorest 180 16.99 1.37 0.000c 17.17 1.52 0.000c 34.17 2.55 0.000c
2nd 181 22.08 2.12 20.30 1.81 42.38 3.56
3rd 179 23.25 2.31 26.14 2.79 49.39 4.80
4th 180 38.83 3.45 49.39 8.14 88.22 10.87
Richest 179 41.60 3.39 55.83 5.11 97.44 7.77
otes: SE, standard error; n, number of caregivers.
a Length of stay included only hospitalized cases of diarrhea (n = 586).
b One-way ANOVA.
c Kruskal–Wallis rank test.
d t-test
Figure 2. Catastrophic health expenditures related to diarrhea in Bangladesh.angladesh in 2011 ($3 in 2018). The study collected information
rom a specific surveillance area and, as a result, had a relatively
maller sample size compared with our study (Rheingans et al.,
012b). Again, as with the other studies mentioned, the Rheingans
t al. study also did not cover all types of facility where caregivers
ought treatment.4
2018 was $79 million. This burden would be higher if it included
cases from all age groups, as found by Sarker et al., who estimated
the annual economic burden of diarrheal diseases to be $172
million in 2015 ($189 million in 2018) (Sarker et al., 2018). The
annual GDP per capita of Bangladesh in 2018 was $1698; based on
this, an average of around 4% of per capita GDP was spent on4
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number of diarrheal admissions creates additional pressure on
hospital services. Therefore, by reducing the incidence of diarrheal
diseases through vaccination programs and other preventative
public-health interventions, high levels of medical time use and
economic costs could be averted. In addition, prevention of
diarrheal illness will reduce the flow of patients to hospitals, which
could save on resources allocated for the infrastructure, hospital
beds, and medical staff required for management of diarrhea cases.
Such saved resources could be allocated for management of other
illness.
Limitations
The limitations of this study include its cross-sectional design
and being hospital based. Moreover, because of self-reported
expenditures and income, it may not have captured seasonal
variations in household income. However, the exit survey was
conducted over a 10-month period at different facilities, which
might have reduced the effects of seasonal variation. The study was
not able to include the costs of emotional effects and adverse
outcomes (such as tiredness and anxiety) experienced by care-
givers during the treatment of diarrhea. However, this could have
over/underestimated the true cost substantially, as these factors do
not have market values, and may have influenced the findings of
the study. Finally, the initial treatment of diarrheal disease often
starts within the households; resources spent during the time prior
to the initial facility visit were not fully covered in this study;
however some information on costs incurred before arriving at the
found that the average economic cost for treating each episode of
diarrhea was $62, amounting to around 4% of the annual national
GDP per capita of 2018. More than 47% of households presenting at
a facility for treatment of diarrheal disease faced a catastrophic
burden of OOP expenditure due to the diarrheal episode. Therefore,
any public-health interventions (e.g., vaccination) that can reduce
the incidence of diarrheal diseases will have the twofold effect of
improving health and alleviating poverty in Bangladesh. Data
generated from this study can inform policymakers in decision
making with regard to prioritization of, and investment in,
diarrheal disease prevention.
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